Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
10,079 results
- GRAVITYIndependent statistical analysis of 12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- GRAY-BIndependent statistical analysis of GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065): Complete Statistical AnalysisIndependent statistical analysis of Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- GRC00097Independent statistical analysis of Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively: primary endpoint results, effect estimate with…
- GReaTIndependent statistical analysis of Gene Regulation by Thiazolidinediones: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00567593).
- GREATIndependent statistical analysis of Get Ready And Empowered About Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02165735).
- Greater Occipital Nerve Block Versus Metoclopramide: Complete Statistical AnalysisIndependent statistical analysis of Greater Occipital Nerve Block Versus Metoclopramide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03269435).
- GRECOIndependent statistical analysis of Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Green Tea and Reduction of Breast Cancer Risk: Complete Statistical AnalysisIndependent statistical analysis of Green Tea and Reduction of Breast Cancer Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00917735).
- Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GreenLight XPS Laser System Retrospective Chart Review: Complete Statistical AnalysisIndependent statistical analysis of GreenLight XPS Laser System Retrospective Chart Review: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02139969).
- GRINIndependent statistical analysis of Testing Preliminary Effectiveness of a Training to Support CHWs Outreach on Dental to African American Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- GRIPHONIndependent statistical analysis of the GRIPHON phase 3 trial of selexipag in pulmonary arterial hypertension, covering its randomized time-to-event endpoint, secondary analyses, statistical methods, confidence intervals, and interpretation.
- Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings: Complete Statistical AnalysisIndependent statistical analysis of Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism: Complete Statistical AnalysisIndependent statistical analysis of Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00206375).
- Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance: Complete Statistical AnalysisIndependent statistical analysis of Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Growth-TBIIndependent statistical analysis of Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00766038).
- GS-US-292-0104Independent statistical analysis of GS-US-292-0104 (NCT01780506), a randomized phase 3 trial comparing E/C/F/TAF with E/C/F/TDF in antiretroviral treatment-naive adults with HIV-1 infection, including its non-inferiority analysis, risk difference, confidence interval, and Cochran-Mantel-Haenszel…
- GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma: Complete Statistical AnalysisIndependent statistical analysis of GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GSK1120212+GSK2141795 for Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of GSK1120212+GSK2141795 for Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01958112).
- GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia: Complete Statistical AnalysisIndependent statistical analysis of GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia: primary endpoint results, effect estimate…
- GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00950807).
- guardian™ 3Independent statistical analysis of Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GUIDE-ITIndependent statistical analysis of Guiding Evidence Based Therapy Using Biomarker Intensified Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01685840).
- GUIDEDIndependent statistical analysis of Genomics Used to Improve DEpression Decisions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02109939).
- GuidePathIndependent statistical analysis of Study of Diagnostic Performance of [18F]CTT1057 in BCR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04838613).
- Gulf War Digestive Health Study: Complete Statistical AnalysisIndependent statistical analysis of Gulf War Digestive Health Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00680836).
- gustinpropIndependent statistical analysis of Gustin Gene Polymorphism and 6-n-propylthiouracil (PROP) Taste: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01097915).
- Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Gut Organoid and Microbiome Interactions in Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Gut Organoid and Microbiome Interactions in Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04497727).
- GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- GVHD ASEDIndependent statistical analysis of A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients: primary endpoint results,…
- GWIIRTIndependent statistical analysis of Gulf War Illness Inflammation Reduction Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02506192).
- GWINISIndependent statistical analysis of Gulf War Illness Nasal Irrigation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01700725).
- GWPCARE5Independent statistical analysis of An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- H2HIndependent statistical analysis of Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- H3MIndependent statistical analysis of Healthy Hearts Healthy Minds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03373110).
- H42/H4UIndependent statistical analysis of Pragmatic Randomized Clinical Trial to Limit Weight Gain in Pregnancy and Prevent Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- HA vs PRPIndependent statistical analysis of Hyaluronic Acid vs Platelet Rich Plasma: Effects on Clinical Outcomes and Intra-articular Biology for the Treatment of Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size…
- HABITSIndependent statistical analysis of Healthy Homes, Healthy Habits: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03433456).
- HAI115879Independent statistical analysis of Dose Ranging of GSK2336805 in Combination Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01648140).
- HALOIndependent statistical analysis of A Study of CIN-107 in Patients With Uncontrolled Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05137002).
- HALO Patient Registry: Ablation of Barrett’s Esophagus: Complete Statistical AnalysisIndependent statistical analysis of HALO Patient Registry: Ablation of Barrett's Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00848237).
- HALT PKD AIndependent statistical analysis of HALT Progression of Polycystic Kidney Disease Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00283686).
- HALT-DIndependent statistical analysis of Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HAMIndependent statistical analysis of Sleep Length and Circadian Regulation in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00843843).
- Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Hand-carried Ultrasound to Assess Hydronephrosis: Complete Statistical AnalysisIndependent statistical analysis of Hand-carried Ultrasound to Assess Hydronephrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03774719).
- Handgrip Exercise for Arteriovenous Fistula Maturation: Complete Statistical AnalysisIndependent statistical analysis of Handgrip Exercise for Arteriovenous Fistula Maturation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01061008).
- Handheld Ultrasound Evaluation of the Inferior Vena Cava to Guide Heart Failure Treatment: Complete Statistical AnalysisIndependent statistical analysis of Handheld Ultrasound Evaluation of the Inferior Vena Cava to Guide Heart Failure Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…